title: Benefit of vaginal sildenafil citrate in assisted reproduction therapy.
authors.forename: Wolfgang E
authors.initials: WE
authors.lastname: Paulus
authors.forename: Erwin
authors.initials: E
authors.lastname: Strehler
authors.forename: Mingmin
authors.initials: M
authors.lastname: Zhang
authors.forename: Ladislava
authors.initials: L
authors.lastname: Jelinkova
authors.forename: Imam
authors.initials: I
authors.lastname: El-Danasouri
authors.forename: Karl
authors.initials: K
authors.lastname: Sterzik
mesh_terms: D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000037:antagonists & inhibitors; D000328:Adult; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010879:Piperazines / Q000627:therapeutic use*; D011687:Purines; D027724:Reproductive Techniques, Assisted; D000068677:Sildenafil Citrate; D013450:Sulfones
chemical_list: D004791:Enzyme Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate; D015106:3',5'-Cyclic-GMP Phosphodiesterases